Researchers have created mice that are 500 times more sensitive than usual to TNT. They could provide a cheap, fast way to find buried explosives.
When he learned in 1995 that he had Alzheimer’s disease, William Utermohlen, an American artist living in London, immediately began work on an ambitious series of self-portraits.
More in Biomedicine
Company pursues breakthrough medicines with proteins unlike any seen in nature.
But the technology for extinguishing species is dividing conservationists.
The blood-testing startup adds a flubbed test for the Zika virus to its rap sheet.
An antibody that clears up brain-destroying plaques may settle the cause of Alzheimer’s once and for all.
A key theory of blood dynamics has been overturned by video evidence showing how red blood cells can make blood less viscous.
The testing of new therapies to prevent a debilitating mitochondrial genetic disease in babies has hit a dead end.
Nobody understands the brain’s wiring diagram, but the tools of algebraic topology are beginning to tease it apart.
A novel solution for Parkinson’s patients who find their treatments wearing off.
A new technique called MAP-seq uses RNA bar codes to quickly and cheaply chart connections between brain cells.
A scientist says a blood test that can discern a fetus’s entire genome is coming.